BTW
ABBV icon

Boston Trust Walden’s AbbVie ABBV Stock Holding History

Boston Trust Walden’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.56M Buy
26,059
+333
+1% +$71.6K 0.05% 220
2026
Q1 		$5.6M Hold
25,726
– – 0.05% 232
2025
Q4 		$5.88M Hold
25,726
– – 0.04% 219
2025
Q3 		$5.96M Buy
25,726
+48
+0.2% +$9.78K 0.04% 218
2025
Q2 		$4.77M Sell
25,678
-122
-0.5% -$22.7K 0.03% 225
2025
Q1 		$5.41M Buy
25,800
+195
+0.8% +$37.9K 0.04% 224
2024
Q4 		$4.55M Sell
25,605
-435
-2% -$80K 0.03% 228
2024
Q3 		$5.14M Buy
26,040
+284
+1% +$53K 0.04% 227
2024
Q2 		$4.42M Buy
25,756
+18
+0.1% +$2.98K 0.03% 227
2024
Q1 		$4.69M Sell
25,738
-450
-2% -$77.6K 0.03% 226
2023
Q4 		$4.06M Sell
26,188
-480
-2% -$70K 0.03% 227
2023
Q3 		$3.98M Buy
26,668
+2,353
+10% +$345K 0.03% 228
2023
Q2 		$3.28M Buy
24,315
+385
+2% +$56.5K 0.03% 233
2023
Q1 		$3.81M Sell
23,930
-300
-1% -$45.9K 0.03% 234
2022
Q4 		$3.92M Sell
24,230
-225
-0.9% -$34.5K 0.03% 238
2022
Q3 		$3.28M Sell
24,455
-450
-2% -$64.6K 0.03% 238
2022
Q2 		$3.81M Sell
24,905
-162
-0.6% -$24.8K 0.04% 238
2022
Q1 		$4.06M Sell
25,067
-1,451
-5% -$211K 0.03% 241
2021
Q4 		$3.59M Buy
26,518
+32
+0.1% +$3.78K 0.03% 248
2021
Q3 		$2.86M Buy
26,486
+100
+0.4% +$11.4K 0.03% 247
2021
Q2 		$2.97M Buy
26,386
+299
+1% +$33.7K 0.03% 250
2021
Q1 		$2.82M Hold
26,087
– – 0.03% 249
2020
Q4 		$2.79M Buy
26,087
+132
+0.5% +$12.7K 0.03% 252
2020
Q3 		$2.27M Sell
25,955
-75
-0.3% -$7.06K 0.03% 259
2020
Q2 		$2.56M Buy
26,030
+276
+1% +$24.3K 0.03% 258
2020
Q1 		$1.96M Sell
25,754
-1,979
-7% -$169K 0.03% 259
2019
Q4 		$2.46M Buy
27,733
+745
+3% +$61.8K 0.03% 260
2019
Q3 		$2.04M Sell
26,988
-275
-1% -$18.9K 0.03% 263
2019
Q2 		$1.98M Buy
27,263
+154
+0.6% +$12.1K 0.03% 270
2019
Q1 		$2.19M Sell
27,109
-52
-0.2% -$4.25K 0.03% 269
2018
Q4 		$2.5M Buy
27,161
+300
+1% +$26.4K 0.04% 258
2018
Q3 		$2.54M Buy
26,861
+299
+1% +$28.4K 0.04% 264
2018
Q2 		$2.46M Sell
26,562
-1,500
-5% -$146K 0.04% 264
2018
Q1 		$2.66M Buy
28,062
+1,350
+5% +$148K 0.04% 258
2017
Q4 		$2.58M Buy
26,712
+750
+3% +$70.7K 0.04% 261
2017
Q3 		$2.31M Sell
25,962
-150
-0.6% -$11.4K 0.04% 269
2017
Q2 		$1.89M Buy
26,112
+3,750
+17% +$252K 0.03% 274
2017
Q1 		$1.46M Sell
22,362
-799
-3% -$50.2K 0.02% 283
2016
Q4 		$1.45M Buy
23,161
+556
+2% +$33.9K 0.02% 281
2016
Q3 		$1.43M Hold
22,605
– – 0.02% 279
2016
Q2 		$1.4M Hold
22,605
– – 0.02% 279
2016
Q1 		$1.29M Sell
22,605
-510
-2% -$28.4K 0.02% 281
2015
Q4 		$1.37M Buy
23,115
+60
+0.3% +$3.46K 0.03% 272
2015
Q3 		$1.25M Buy
23,055
+663
+3% +$43.2K 0.02% 281
2015
Q2 		$1.5M Sell
22,392
-2,254
-9% -$147K 0.02% 271
2015
Q1 		$1.44M Hold
24,646
– – 0.02% 264
2014
Q4 		$1.61M Sell
24,646
-700
-3% -$44.1K 0.02% 260
2014
Q3 		$1.46M Buy
25,346
+390
+2% +$21.7K 0.02% 258
2014
Q2 		$1.41M Sell
24,956
-1,300
-5% -$68.2K 0.02% 257
2014
Q1 		$1.35M Sell
26,256
-200
-0.8% -$10.1K 0.02% 245
2013
Q4 		$1.4M Sell
26,456
-1,251
-5% -$61.5K 0.02% 245
2013
Q3 		$1.24M Sell
27,707
-1,000
-3% -$44.3K 0.02% 243
2013
Q2 		$1.19M Buy
+28,707
New +$1.26M 0.02% 235

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Boston Trust Walden's ABBV Position: Q2 2026 in Review

Boston Trust Walden increased its AbbVie (ABBV) stake by 1.3% in Q2 2026, buying an estimated $71.6K and bringing the position to 26,059 shares worth $6.56M. The position accounts for 0.05% of the portfolio, ranked #220.

Boston Trust Walden first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 1,939 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Boston Trust Walden held 26,059 shares of AbbVie worth $6.56M as of Q2 2026.
  • Boston Trust Walden bought 333 AbbVie shares in Q2 2026, an estimated $71.6K.
  • AbbVie made up 0.05% of Boston Trust Walden's portfolio in Q2 2026, its #220 holding.
  • Boston Trust Walden first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 1,939 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.